ERS Genomics
ERS Genomics Licenses CRISPR-Cas9 Portfolio to Cellular Engineering Technologies
CET said it will integrate its stem cell technology with CRISPR-Cas9 to create next-generation stem cells for life science research.
ERS Genomics Licenses CRISPR IP to Japan SLC
Japan SLC, a biotechnology company providing animal models to the research community, will use the license to expand its offerings.
ERS Genomics Licenses CRISPR IP to GenOway
ERS Genomics was founded to provide access to CRISPR-Cas9 intellectual property shared by Emmanuelle Charpentier, Jennifer Doudna, and others.
ERS Genomics Licenses CRISPR Patents to GenScript Biotech
GenScript said it will use the license to improve its own synthetic sgRNA, gRNA plasmid, gRNA library, and cell line engineering services.
ERS Genomics Licenses CRISPR Patents to Nuvisan
Nuvisan, based in Waltrop, Germany, will use ERS'w Genomics CRISPR-Cas9 portfolio to help advance its clients' drug discovery and early development programs.
Mar 10, 2021
ERS Genomics Licenses CRISPR Patents to Setsuro Tech
Dec 13, 2018